Table 1.

Demographic and Clinical Characteristics of Study Group

Characteristic	Control Group (N=23)	Intervention Group (N=23)	P-value
	Mean (SD) or %	Mean (SD) or %
Age	52.6 (.90)	51.96 (5.2)	0.65
Gender			0.77
Male	57	61
Female	43	39
Race			0.35
Black	96	87
White	4	4
Other	0	9
Years since HIV Dx	15 (1.62)	16.17 (1.57)	0.61
Years since BP Dx	10.14 (1.95)	12.3 (2.37)	0.48
Years since DM Dx	6.5 (1.58)	5.5 (1.41)	0.66
CD4 cell count (cells/mm 3 )
≤200	13	13	0.90
201–499	48	57
≥500	30	26
Missing	9	4
HIV1 RNALevel (copies/ml)
<200	52	61	0.76
≥200	39	35
Missing	9	4
At Risk for Poor Health Literacy (REALM-R)			0.30
No	39	43	0.77
Yes	61	57
Current Smoking
Yes	65	61	0.76
No	35	39
Insurance
Private	9	13	0.02
Public	87	52
Uninsured	4	35
Uses pillbox
Yes	47	61	0.38
No	52	39
Education
Less than college	74	87	0.27
Any college	26	13
Depression screening (PHQ 9)
None/Mild symptoms	35	39	0.90
Moderate symptoms	48	48
Severe symptoms	17	13
Social Support (FSSQ) *	3.73 (0.22)	3.55 (0.28)	0.61
Self Efficacy (SEAMS) **	32 (6)	31 (6)	0.55
Medication understanding (MUQ) ‡	0.78 (0.12)	0.79 (0.10)	0.74
Baseline number of medications	8.4 (2.8)	8.0 (2.2)	0.60
Baseline number of comorbidities	3.1 (1.9)	3.7 (1.9)	0.30

^*FSSQ score Range: 1 to 5 (low to high social support)

^**SEAMS score range: 13 to 39 (low to high self efficacy)

^‡MUQ score range: 0 to 1 (low to high understanding)